Charles Zhu
Stock Analyst at LifeSci Capital
(1.4)
# 1605
Out of 5,333 analysts
26
Total ratings
50.00%
Success rate
15.53%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
TNGX Tango Therapeutics | Maintains: Buy | 18 8 | 1.11 | 620.72% | 3 | Nov 7, 2024 | |
MGNX Macrogenics | Upgrades: Buy | 12 | 1.42 | 745.07% | 4 | Nov 7, 2023 | |
MRUS Merus | Maintains: Strong Buy | 46 48 | 41 | 17.07% | 6 | Aug 8, 2023 | |
NUVL Nuvalent | Initiates Coverage On: Buy | 56 | 69.94 | -19.93% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 3.25 | 576.92% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 4.84 | 437.19% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 17.48 | 83.07% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 11.31 | 23.78% | 2 | May 5, 2022 |